- Posterpreise
- Projektförderungen
-
Projektdatenbank
- Projekt 50
- Projekt 49
- Projekt 48
- Projekt 47
- Projekt 46
- Projekt 45
- Projekt 44
- Projekt 43
- Projekt 42
- Projekt 41
- Projekt 40
- Projekt 39 advanced scholarship
- Projekt 38 advanced scholarship 2016 I
- Projekt 37
- Projekt 36
- Projekt 35
- Projekt 34
- Projekt 33
- Projekt 32 advanced scholarship 2
- Projekt 31
- Projekt 30
- Projekt 29
- Projekt 28
- Advanced scholarship
- Projekt 26
- Projekt 25
- Projekt 24
- Projekt 23
- Projekt 22
- Projekt 21
- Projekt 21A
- Projekt 20
- Projekt 19
- Projekt 18
- Projekt 17
- Projekt 16
- Projekt 15
- Projekt 14
- Projekt 13
- Projekt 12
- Projekt 11
- Projekt 10
- Projekt 9
- Projekt 8
- Projekt 6
- Projekt 5
- Projekt 4
- Projekt 7
- Projekt 3A
- Projekt 3
- Projekt 2
- Projekt 1
- Symposien
Investigating a novel phenotype of lysosomal dysfunction in spartin-HSP
Rachel Allison, Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research
Project Summary
A defining feature of nerve cells (neurons) is that they rapidly communicate over long distances. This communication is provided by direct connections between neurons in cable-like structures called axons. However, sometimes axons become unhealthy and degenenerate. This is a key event in the progression of a number of major neurodegenerative diseases, including the hereditary spastic paraplegias (HSPs). A fundamental question in neuroscience is understanding the molecular mechanisms required to maintain healthy axons. I aim to help answer this question and do so by studying HSP.
The HSPs are a group of inherited neurological disorders, the main pathological feature of which is the degeneration of the longest axons in the spinal cord. As HSPs are genetic conditions, identifying the responsible genes enables identification of specific proteins required for axon health. Previously my work has focussed on the cell biology of spastin (SPG4), mutations in which are the most common cause of HSP. This work has shown that spastin is essential for the normal cellular functions of the lysosome (the cellular degradation and recycling centre). This is emerging as a common theme in HSP, and many known HSP proteins have a role at the lysosome.
In this project, I will focus on defining the cell biology of spartin (SPG20) in lysosomal function. Gene mutations causing loss of spartin are responsible for Troyer syndrome, a type of HSP. I will investigate the mechanisms by which spartin controls lysosome function and the effects of spartin loss on these processes. This project will help confirm the importance of lysosome function as a key regulatory point in HSP and further our understanding of the cellular basis of the disease. It has the potential to assist in the development of therapeutic strategies, via identification of drug targets that may be globally relevant or unique to a specific class of HSP.